ASTFX | LTEFX | ASTFX / LTEFX | |
Total Expense Ratio | 0.31 | 0.37 | 84% |
Annual Report Gross Expense Ratio | 0.32 | 0.37 | 86% |
Fund Existence | 16 years | 17 years | - |
Gain YTD | 0.403 | 0.196 | 205% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 250 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.99B | 5.4B | 37% |
Annual Yield % from dividends | 2.80 | 2.72 | 103% |
Returns for 1 year | 1.17 | 0.85 | 137% |
Returns for 3 years | 1.68 | 2.40 | 70% |
Returns for 5 years | -2.75 | -4.04 | 68% |
Returns for 10 years | -0.12 | -1.14 | 11% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
JUNZ | 29.77 | N/A | N/A |
TrueShares Structured Outcome June ETF | |||
JMUB | 49.41 | -0.07 | -0.14% |
JPMorgan Municipal ETF | |||
RAYE | 25.42 | -0.11 | -0.43% |
Rayliant Quantamental Emer Mkt Eq ETF | |||
IHE | 67.50 | -0.37 | -0.55% |
iShares US Pharmaceuticals ETF | |||
UAPR | 30.76 | -0.19 | -0.61% |
Innovator U.S. Equity Ultra BffrETF™-Apr |